Irritable Bowel Syndrome is the:
- Second most frequently encountered diagnosis in clinical practice. (1)
- Accounts for more physician visits than any symptom except for respiratory tract infections. (1)
- Most frequent diagnosis made in typical gastroenterologist's practice. (1)
If you suffer from IBS symptoms - especially from diarrhea and cramping - you may want to ask your healthcare professional
about Donnatal Extentabs®.
All Day, All Night... Donnatal Extentabs®
Donnatal Extentabs® are an extended release, combination antispasmodic therapy with a history of
trust for nearly 30 years.
More than 40,000 patient days per year have been prescribed by physicians in the antispasmodic category of therapy since 1991. (2)
Of all the options available in this type of therapy, only Donnatal Extentabs® provide gradual dissolution over 12 hours,
distinctively longer than immediate release tablets. (3)
The Benefits of Extended Release
"Extentabs" is an extended release therapy, affording patient convenience day and night with 12-hour dosing.
The nighttime benefit afforded by extended release is important to IBS sufferers whose symptoms occurring through the night
prevent a full night's rest. Without proper rest at night, quality of life may be affected as well as the ability to be
productive in school or in the workplace.
For stocking assistance, please contact PBM Pharmaceuticals, Inc. at the following number:
1-800-959-2066 ext. 156
How Supplied: Donnatal Extentabs® Tablets are supplied as: film coated green, round, compressed tablets printed "P421"
in black ink.
Bottles of 100 tablets NDC 66213-421-10.
Bottles of 500 tablets NDC 66213-421-50.
There is no generic multisource version of Donnatal Extentabs®.
1) Engstrom, PF, Grossenberg, EB. Diagnosis and Management of Bowel Disease, First Edition, 1999; 2:64.
2) Source Prescription Audit (SPA), Verispan, November 2002.
3) Data on File, PBM Pharmaceuticals.
|
